Propanc Biopharma (PPCB) Short Interest Ratio & Short Volume

Short interest is the volume of Propanc Biopharma shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 6,200 shares of PPCB short. Learn More on Propanc Biopharma's current short interest.

Propanc Biopharma saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 6,200 shares, an increase of ∞ from the previous total of 0 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to Propanc Biopharma: Amarantus BioScience Holdings, Inc. (0.00%), RegeneRx Biopharmaceuticals, Inc. (0.01%), Adhera Therapeutics, Inc. (0.00%), Predictive Technology Group, Inc. (0.00%), Acura Pharmaceuticals, Inc. (0.01%), GelStat Corp. (0.00%), NovAccess Global Inc. (0.00%), ReNeuron Group plc (0.00%), Bruush Oral Care Inc. (77.14%), Oncology Pharma Inc. (0.03%), and

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

Short selling PPCB is an investing strategy that aims to generate trading profit from Propanc Biopharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Propanc Biopharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PPCB, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PPCB, twice per month. The most recent reporting period available is March, 31 2024.